STOCK TITAN

INNOVATION PHARMACEUTICAL (IPIX) Net Income by Year

IPIX

INNOVATION PHARMACEUTICAL reported a net loss of $3.2M in fiscal year 2023. This represents an increase of 55.0% from the prior fiscal year. The table below carries 15 fiscal years, from 2009 to 2023, and the quarters INNOVATION PHARMACEUTICAL has filed alongside them.

FY2023 annual
Net Income -$3.2M
YoY +55.0%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2024, ended Sep 30, 2023 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

IPIX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-KFY0910-K
Net Income-$3.2M+55.0%-$7.0M+49.2%-$13.9M-108.7%-$6.6M+23.4%-$8.7M+46.9%-$16.4M-5.3%-$15.5M-20.9%-$12.9M+2.2%-$13.1M-59.4%-$8.2M-155.8%-$3.2MN/AN/A-$3.4M-131.2%-$1.5M

IPIX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2410-QQ4'2310-QQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-QQ4'2110-KQ3'2110-QQ2'2110-Q
Net Income-$880K+38.4%N/A-$698K+53.0%-$361K+80.7%-$1.4M+30.5%N/A-$1.5M+62.5%-$1.9M+69.7%-$2.1M-75.3%N/A-$4.0M-298.0%-$6.2M-135.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More INNOVATION PHARMACEUTICAL financials

Frequently Asked Questions

What was INNOVATION PHARMACEUTICAL's net income in fiscal year 2023?

INNOVATION PHARMACEUTICAL reported a net loss of $3.2M in fiscal year 2023.

How fast is INNOVATION PHARMACEUTICAL's net income growing?

INNOVATION PHARMACEUTICAL (IPIX) net income rose by 55.0% year over year, from -$7.0M to -$3.2M in fiscal year 2023.

How has INNOVATION PHARMACEUTICAL's net income changed over the years?

Across the 15 fiscal years this page covers, INNOVATION PHARMACEUTICAL (IPIX) net income went from -$1.5M in fiscal year 2009 to -$3.2M in fiscal year 2023.

INNOVATION PHARMACEUTICAL (IPIX) reported -$880K in net income in Q1 2024. This represents an increase of 38.4% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what INNOVATION PHARMACEUTICAL (IPIX) reported on that line in every period on record.